[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Baskent University Ankara Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":67},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100567801","impact-of-standardized-skin-to-skin-care-on-clinical-outcomes-in-infants-born--32-weeks-a-multicenter-study-100567801",false,"NCT06672913","Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study","TR-SSCinNICU","Inclusion Criteria:\n\n* Infants born at gestational age ≤ 32 weeks\n\nExclusion Criteria:\n\n* Death before NICU discharge\n* Abdominal wall defects","ALL","1 Day",{"count":19,"type":20},120,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study is a multi-center, prospective pre-post clinical study conducted under the leadership of the Turkish Neonatal Society. It aims to investigate the effects of a standardized skin-to-skin care in NICU, initiated early and applied regularly, on recieving exclusive mothers' milk at discharge and clinical outcomes for preterm infants born ≤ 32 weeks of gestation.\n\n1. Primary Objective: To evaluate the rate of receiving exclusive mothers' milk at discharge for infants born ≤ 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.\n2. Secondary Objective: To evaluate the rates of neonatal sepsis, intraventricular hemorrhage, and necrotizing enterocolitis (stage 2 and above) as well as the length of hospital stay for infants born at or below 32 weeks of gestation who have received skin-to-skin care in accordance with the study protocol.",[26,27,28,29,30],"Premature","Skin to Skin Contact","Breast Feeding","Necrotizing Enterocolitis","Retinopathy of Prematurity",[26,32,28,29,30],"Skin to skin contact","RECRUITING","2024-11-01",{"date":36,"type":37},"2024-11-04","ACTUAL",{"date":39,"type":37},"2024-09-01",{"date":41,"type":20},"2025-06-01",{"name":43,"class":44},"Baskent University Ankara Hospital","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":54,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":4,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":45},"100536479","evaluation-of-the-frequency-risk-factors-and-outcomes-of-rop-in-infants-with-a-bw-1500-grs-or-ga-33-wks-in-turkey-100536479","NCT06265363","Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants With a BW >1500 Grs or GA ≥33 Wks in Turkey.","Evaluation of the Frequency of Retinopathy of Prematurity, Influencing Risk Factors, and Treatment Outcomes in Premature Infants With a Birth Weight >1500 Grams or Gestational Age ≥33 Weeks in Turkey.","TR-ROP-2","Inclusion Criteria:\n\n* Infants with BW \\>1500 g or ≥33 weeks' gestation who were determined to be at risk for ROP by the attending clinician and were screened for ROP.\n\nExclusion Criteria:\n\n* Neonates who died before the first ROP examination are excluded from the study.","28 Days",{"count":56,"type":20},1000,"OBSERVATIONAL","The study includes preterm infants who are being screened for ROP between August 1,2023 and August 1, 2024 in 94 neonatal intensive care units (NICUs) in Turkey. Infants with birth weight (BW) of \\>1500 g or ≥ 33 weeks' gestation who are screened for retinopathy of prematurity are included. The incidence of any ROP, severe ROP and treatment modalities will be determined. The risk factors for ROP development will also be evaluated.",[30],"2024-10-31",{"date":34,"type":37},{"date":63,"type":37},"2023-08-01",{"date":65,"type":20},"2024-12-01",{"name":43,"class":44},""]